✦ LIBER ✦

1163 The efficacy of oligonucleotide chip detecting YMDD mutants of hepatitis B virus in lamivudine-treated patients

✍ Scribed by HEO, J; CHO, M; KIM, G; KANG, D; SONG, G; YANG, U; JANG, H; PARK, H; KIM, C; KIM, H

Book ID: 123290395
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 289 KB
Volume: 38
Category: Article
ISSN: 0270-9139
DOI: 10.1016/S0270-9139(03)81201-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rate of YMDD motif mutants in lamivudine

Rate of YMDD motif mutants in lamivudine-untreated Iranian patients with chronic hepatitis B virus infection

✍ Amitis Ramezani; Ali Akbar Velayati; Mohammad Reza Hasanjani Roshan; Latif Gachk 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Dynamic changes of hepatitis B virus pol

Dynamic changes of hepatitis B virus polymerase gene including YMDD motif in lamivudine-treated patients with chronic hepatitis B

✍ Bo Feng; Lai Wei; Ming Chen; Liping Wang 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 358 KB

Initial viral response is the most power

Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine

✍ Nao Kurashige; Naoki Hiramatsu; Kazuyoshi Ohkawa; Tsugiko Oze; Yuko Inoue; Mika 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

Early detection and quantification of la

Early detection and quantification of lamivudine-resistant hepatitis B virus mutants by fluorescent biprobe hybridization assay in lamivudine-treated patients

✍ Fumi Umeoka; Yoshiaki Iwasaki; Masayuki Matsumura; Akinobu Takaki; Haruhiko Koba 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 313 KB

Application of PCR-LDR-nucleic acid dete

Application of PCR-LDR-nucleic acid detection strip in detection of YMDD mutation in hepatitis B patients treated with lamivudine

✍ Gaolian Xu; Qimin You; Sam Pickerill; Huayan Zhong; Hongying Wang; Jian Shi; Yin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

## Abstract Chronic hepatitis B virus (CHBV) infection causes cirrhosis and hepatocellular carcinoma. Lamivudine (LAM) has been successfully used to treat CHBV infections but prolonged use leads to the emergence of drug‐resistant variants. This is primarily linked to a mutation in the tyrosine–meth

Rapid quantitation of lamivudine-resista

Rapid quantitation of lamivudine-resistant mutants in lamivudine treated and untreated patients with chronic hepatitis B virus infection

✍ Ming Shi; Zhi-Jun Yang; Rong-Sheng Wang; Hua Zhang; Yu-Fen Zhu; Yong-Ping Xu; Qi 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 223 KB